Tag: $Dice Therapeutics

Eli Lilly to Buy DICE Therapeutics in $2.4 Billion Autoimmune Disease Push

Eli Lilly has agreed to buy DICE Therapeutics in a $2.4 billion cash deal that reflects Lilly’s ambitions in immunology, a hot market where the company has lagged behind its coompetitors.